Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,806 | 78 | 94.0% |
| Education | $114.41 | 2 | 6.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $342.23 | 24 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $312.10 | 17 | $0 (2021) |
| Boston Scientific Corporation | $298.89 | 5 | $0 (2024) |
| PFIZER INC. | $173.87 | 10 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $171.19 | 2 | $0 (2022) |
| Astellas Pharma US Inc | $166.85 | 5 | $0 (2021) |
| Novo Nordisk Inc | $110.55 | 1 | $0 (2022) |
| Amgen Inc. | $85.81 | 4 | $0 (2022) |
| Esperion Therapeutics, Inc. | $83.39 | 5 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $67.20 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $330.89 | 6 | Boston Scientific Corporation ($263.69) |
| 2022 | $318.64 | 9 | Novo Nordisk Inc ($110.55) |
| 2021 | $835.56 | 41 | E.R. Squibb & Sons, L.L.C. ($270.94) |
| 2020 | $435.59 | 24 | AstraZeneca Pharmaceuticals LP ($195.71) |
All Payment Transactions
80 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/08/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $160.42 | General |
| Category: AVVIGO_IC | ||||||
| 01/30/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $98.73 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 01/26/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $4.54 | General |
| Category: General - Balloon Catheters_ICG | ||||||
| 06/13/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $97.18 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/03/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/12/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/02/2022 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $110.55 | General |
| 03/17/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $29.09 | General |
| Category: Cardiology | ||||||
| 03/16/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/14/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/24/2022 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/21/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2021 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $74.01 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/11/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: Cardiovascular | ||||||
| 11/10/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/02/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $12.46 | General |
| 10/11/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: Cardiology | ||||||
| 09/28/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/28/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $1.38 | General |
| Category: Cardiovascular | ||||||
| 08/27/2021 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 08/17/2021 | Astellas Pharma US Inc | LEXISCAN (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 08/12/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
About Tripti Gupta
Tripti Gupta is a Adult Congenital Heart Disease healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/18/2016. The National Provider Identifier (NPI) number assigned to this provider is 1306290242.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Tripti Gupta has received a total of $1,921 in payments from pharmaceutical and medical device companies, with $330.89 received in 2024. These payments were reported across 80 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,806).
Practice Information
- Specialty Adult Congenital Heart Disease
- Other Specialties Student in an Organized Health Care Education/Training Program, Cardiovascular Disease
- Location San Diego, CA
- Active Since 04/18/2016
- Last Updated 06/13/2024
- Taxonomy Code 207RA0002X
- Entity Type Individual
- NPI Number 1306290242
Products in Payments
- ELIQUIS (Drug) $465.08
- LifeVest (Device) $171.19
- AVVIGO Guidance System (Device) $160.42
- BRILINTA (Drug) $144.30
- FARXIGA (Drug) $99.54
- NEXLETOL (Drug) $83.39
- LEXISCAN (Drug) $67.85
- Repatha (Biological) $63.85
- ENTRESTO (Drug) $44.72
- Tandem Life Kit (Device) $42.21
- Vascular Lithotripsy (Device) $37.98
- LEQVIO (Drug) $22.48
- VYNDAQEL (Drug) $20.89
- WATCHMAN (Device) $18.71
- GENERAL - VASCULAR INTERVENTION (Device) $16.49
- Acticor (Device) $15.41
- LOKELMA (Drug) $13.68
- Tandem Heart Kit (Device) $13.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.